Pharmacists in Barrington, NJ Accepting Medicare

6 Pharmacists found. Showing 1 - 6

Dr. Cinzia Bonomo, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 501 Clements Bridge Rd, Barrington, NJ 08007 Phone: 856-547-3200

Mrs. Nuzhat Salim, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 501 Clements Bridge Rd, Barrington, NJ 08007 Phone: 856-547-3200

Mr. Richard Kress, R.PH,CCP,FASCP Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 208 White Horse Pike, Suite #9, Barrington, NJ 08007 Phone: 856-323-8723    Fax: 856-323-8577

Mr. Carl A Ballier, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 501 Clements Bridge Rd, Barrington, NJ 08007 Phone: 856-547-3200    Fax: 856-547-5283

Kirk Myers, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 501 Clements Bridge Rd, Barrington, NJ 08007 Phone: 856-547-3200

Matthew Rappe, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 501 Clements Bridge Rd, Barrington, NJ 08007 Phone: 856-547-3200

News Archive

Acorda Therapeutics receives U.S. patent allowance for aminopyridine compositions

Acorda Therapeutics, Inc. today announced that the United States Patent and Trademark Office (USPTO) has allowed U.S. Patent Application No. 11/102,559 entitled "Method of Using Sustained Release Aminopyridine Compositions."

MIT offer logitics solution to Flu vaccine shortages

Although the flu causes tens of thousands of deaths each year in the United States, vaccine to fight the illness is often in short supply when the flu season is at its peak.

University of Colorado receives $6.3 million for umbilical cord blood bank

The University of Colorado Cord Blood Bank, a component of ClinImmune Labs and the University of Colorado School of Medicine, has been awarded $6.3 million to collect and bank umbilical cord blood, with an emphasis on donors from minority groups.

Combination therapy for pediatric low-grade gliomas shows promise in mice

In experiments with human cells and mice, researchers at the Johns Hopkins Kimmel Cancer Center report evidence that combining the experimental cancer medication TAK228 (also called sapanisertib) with an existing anti-cancer drug called trametinib may be more effective than either drug alone in decreasing the growth of pediatric low-grade gliomas.

Read more Medical News

› Verified 9 days ago